Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-24-047813
Filing Date
2024-11-26
Accepted
2024-11-26 16:15:28
Documents
1
Period of Report
2024-11-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1548
  Complete submission text file 0001493152-24-047813.txt   3056
Mailing Address 324 SOUTH HYDE PARK AVENUE, SUITE 350 TAMPA FL 33606
Business Address 1200 BRICKELL AVENUE SUITE 1950 #1183 MIAMI FL 33131 813-369-5150
MIRA PHARMACEUTICALS, INC. (Issuer) CIK: 0001904286 (see all company filings)

EIN.: 853354547 | State of Incorp.: FL
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 855 N WOLFE STREET, SUITE 601 BALTIMORE MD 21205
Business Address
Whalen Matthew Pratt (Reporting) CIK: 0002033867 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41765 | Film No.: 241503983